|
Real-time Estimate
Cboe Europe
15:30:58 13/08/2026 BST
|
5-day change | 1st Jan Change | ||
| 546.25 SEK | -0.14% |
|
+4.64% | +0.64% |
| 07-22 | SEB raises Medcap price target to 660 kronor (630), reiterates buy | FW |
| 07-21 | MedCap AB Reports Earnings Results for the Second Quarter and Six Months Ended June 30, 2026 | CI |
Company Valuation: MedCap AB
Data adjusted to current consolidation scope
| Fiscal Period: December | 2023 | 2024 | 2025 | 2026 | 2027 | 2028 |
|---|---|---|---|---|---|---|
| Market Cap 1 | 4,997 | 8,899 | 8,278 | 8,192 | - | - |
| Change | - | 78.07% | -6.99% | -1.04% | - | - |
| Enterprise Value (EV) 1 | 4,997 | 9,176 | 8,359 | 8,275 | 8,037 | 7,796 |
| Change | - | 83.61% | -8.9% | -1.01% | -2.88% | -2.99% |
| P/E | 29.1x | 42.9x | - | 32.2x | 27.4x | 24.2x |
| PBR | - | 6.95x | - | 4.78x | 4.06x | 3.48x |
| PEG | - | 2.1x | - | - | 1.6x | 1.8x |
| Capitalization / Revenue | - | 4.93x | 3.93x | 3.42x | 3.05x | 2.8x |
| EV / Revenue | - | 5.08x | 3.97x | 3.45x | 2.99x | 2.66x |
| EV / EBITDA | - | 23.7x | 18.3x | 15x | 12.7x | 11.2x |
| EV / EBIT | - | 33.7x | 27.6x | 22.4x | 18.4x | 16.3x |
| EV / FCF | - | 28.8x | 26.4x | 44.7x | 22.4x | 18.9x |
| FCF Yield | - | 3.47% | 3.79% | 2.24% | 4.47% | 5.28% |
| Dividend per Share 2 | - | - | - | - | - | - |
| Rate of return | - | - | - | - | - | - |
| EPS 2 | 11.6 | 14 | - | 16.97 | 19.95 | 22.62 |
| Distribution rate | - | - | - | - | - | - |
| Net sales 1 | - | 1,807 | 2,108 | 2,398 | 2,686 | 2,927 |
| EBITDA 1 | - | 387.7 | 456.3 | 551.5 | 632 | 694 |
| EBIT 1 | - | 272.3 | 302.9 | 370 | 437 | 479.5 |
| Net income 1 | 172.2 | 207.4 | 219.8 | 258 | 319 | 356 |
| Net Debt 1 | - | 276.5 | 81.3 | 83 | -155 | -395.5 |
| Reference price 2 | 337.50 | 601.00 | 549.00 | 547.00 | 547.00 | 547.00 |
| Nbr of stocks (in thousands) | 14,807 | 14,807 | 15,078 | 14,976 | - | - |
| Announcement Date | 31/01/24 | 31/01/25 | 05/02/26 | - | - | - |
1SEK in Million2SEK
Estimates
P/E, Detailed evolution
| P/E (N) | EV / Sales (N) | EV / EBITDA (N) | Dividend Yield (N) | Capi.($) | ||
|---|---|---|---|---|---|---|
 | - | 3.45x | 15x | - | 858M | |
| 30.33x | 12.71x | 21.16x | 1.58% | 42.47B | |
| 16.84x | 9.03x | 14.43x | 6.25% | 23.21B | |
| 20.85x | 9.19x | 14.95x | 3.28% | 18.38B | |
| 25.95x | 5.02x | 8.74x | 2.91% | 4.03B | |
| 7.77x | 0.93x | 5x | 4.83% | 1.27B | |
| 13.98x | 12.87x | 13.24x | 5.08% | 914M | |
| 9.16x | 9.3x | 9.51x | 5.87% | 844M | |
| Average | 17.84x | 7.81x | 12.75x | 4.26% | 11.5B | |
| Weighted average by Cap. | 24.11x | 10.46x | 17.21x | 3.29% |
Y-o-Y evolution of P/E
Historical PBR trend
Evolution Enterprise Value / Sales
Change in Enterprise Value/EBITDA
- Stock Market
- Stocks
- MCAP Stock
- Valuation MedCap AB
Select your edition
All financial news and data tailored to specific country editions
